Principles of Economic Evaluation in a Pandemic Setting: An Expert Panel Discussion on Value Assessment During the Coronavirus Disease 2019 Pandemic Yumi AsukaiAndrew BriggsDaniel A. Ollendorf Current Opinion Open access 24 September 2021 Pages: 1201 - 1208
The Challenges of Measuring Informal Care Time: A Review of the Literature Sean UrwinYiu-Shing LauMatt Sutton Review Article Open access 29 July 2021 Pages: 1209 - 1223
The Use of Cost-Effectiveness Analysis in Sickle Cell Disease: A Critical Review of the Literature Boshen JiaoAnirban BasuBeth Devine Review Article 09 August 2021 Pages: 1225 - 1241
How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment Michael SchlanderKarla Hernandez-VillafuerteMichael Baumann Systematic Review Open access 09 August 2021 Pages: 1243 - 1269
A Systematic Review of Economic and Quality-of-Life Research in Carcinoid Syndrome I-Wen PanDaniel M. HalperinYa-Chen Tina Shih Systematic Review 11 August 2021 Pages: 1271 - 1297
EQ-5D-Y Population Norms for Japanese Children and Adolescents Takeru ShiroiwaTakashi Fukuda Original Research Article Open access 22 July 2021 Pages: 1299 - 1308
Cost Effectiveness of Triplet Selinexor-Bortezomib-Dexamethasone (XVd) in Previously Treated Multiple Myeloma (MM) Based on Results from the Phase III BOSTON Trial Michael DolphGabriel TremblayHoyee Leong Original Research Article Open access 09 August 2021 Pages: 1309 - 1325
Cost Effectiveness of Screening for Hepatitis C Virus in Iraq in the Era of Simplified Testing and Treatment Bassem AskerRaghad JawadHaidar Jarallah Original Research Article Open access 16 August 2021 Pages: 1327 - 1341
Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective Adnan AlsumaliLaurence M DjatcheDominik Lautsch Original Research Article Open access 08 October 2021 Pages: 1343 - 1354